Katy B. Murray

Larbert, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

UK consensus on pregnancy in multiple sclerosis: An update to 'Association of British Neurologists' guidance.

UK consensus on pregnancy in multiple sclerosis: An update to 'Association of British Neurologists' guidance.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 03, 2026

The Contribution of Baseline Circulating Endocannabinoids to Individual Differences in Human Pain Sensitivity: A Quantitative Sensory Testing Study.

The Contribution of Baseline Circulating Endocannabinoids to Individual Differences in Human Pain Sensitivity: A Quantitative Sensory Testing Study.

Journal: bioRxiv : the preprint server for biology
Published: September 05, 2025

The contribution of baseline circulating endocannabinoids to individual differences in human pain sensitivity: a quantitative sensory testing study.

The contribution of baseline circulating endocannabinoids to individual differences in human pain sensitivity: a quantitative sensory testing study.

Journal: Pain
Published: August 28, 2025

Approach to JCV testing with natalizumab biosimilar: a UK consensus statement.

Approach to JCV testing with natalizumab biosimilar: a UK consensus statement.

Journal: Multiple sclerosis and related disorders
Published: March 24, 2025

Using disease-modifying treatments in multiple sclerosis: Association of British Neurologists (ABN) 2024 guidance.

Using disease-modifying treatments in multiple sclerosis: Association of British Neurologists (ABN) 2024 guidance.

Journal: Practical neurology
Published: October 01, 2024

Assessing the landscape and charting paths: UK neurology trainees' opinions on neuroinflammation subspecialty.

Assessing the landscape and charting paths: UK neurology trainees' opinions on neuroinflammation subspecialty.

Journal: Multiple sclerosis and related disorders
Published: June 29, 2024

Fatigue in early multiple sclerosis: MRI metrics of neuroinflammation, relapse and neurodegeneration.

Fatigue in early multiple sclerosis: MRI metrics of neuroinflammation, relapse and neurodegeneration.

Journal: Brain communications
Published: February 22, 2024

Developing evidence-based guidelines for the safety of symptomatic drugs in multiple sclerosis during pregnancy and breastfeeding: A systematic review and Delphi consensus.

Developing evidence-based guidelines for the safety of symptomatic drugs in multiple sclerosis during pregnancy and breastfeeding: A systematic review and Delphi consensus.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: February 06, 2023

Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines.

Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines.

Journal: Practical neurology
Published: June 13, 2022

Predictors of relapse in MOG antibody associated disease: a cohort study.

Predictors of relapse in MOG antibody associated disease: a cohort study.

Journal: BMJ open
Published: December 01, 2021

UK variance in DMT advice and prescribing in MS and pregnancy: Impact of the UK consensus on pregnancy in multiple sclerosis ABN guidelines.

UK variance in DMT advice and prescribing in MS and pregnancy: Impact of the UK consensus on pregnancy in multiple sclerosis ABN guidelines.

Journal: Multiple sclerosis and related disorders
Published: June 25, 2021

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients.

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients.

Journal: Multiple sclerosis and related disorders
Published: March 11, 2020
Showing 1-12 of 18

Last Updated: 09/26/2026